Lishan Aklog, MD

Co-Founder and Chairman

Dr. Aklog is an heart surgeon, entrepreneur and Chairman & CEO of PAVmed Inc. (Nasdaq: PAVM), a multi-product medical device company which he co-founded based in 2014 and took public on Nasdaq in 2016.  He also serves as co-founding Partner of both Pavilion Holdings Group (PHG), a medical device holding company and Pavilion Medical Innovations, its venture-backed medical device incubator. Dr. Aklog previously served as Chairman and Chief Technology Officer of Vortex Medical Inc., a PHG portfolio company which was acquired by AngioDynamics Inc. (Nasdaq: ANGO) for $55 million. Dr. Aklog has been a consultant to Biomet Inc., now Zimmer Biomet (NYSE: ZBH), AngioDynamics, Edward Lifesciences Corp. (NYSE: EW), On-X Life Technologies Inc. and Atricure Inc. (Nasdaq: ATRC) and has served on the Scientific Advisory Boards of numerous leading medical device companies, including Medtronic, St. Jude Medical, Guidant Cardiac Surgery (now, Maquet Cardiovascular) and Cardiovations (then, a division of Johnson & Johnson).

Prior to entering the medical device industry full-time in 2012, Dr. Aklog had a distinguished career as an academic cardiac surgeon, practicing and teaching heart surgery and performing research at major academic medical centers.  He served as Assistant Professor of Surgery at Harvard Medical School, Director of the Cardiac Surgery Research Laboratory and an attending cardiac surgeon at Brigham and Women’s Hospital; Assistant Professor of Cardiothoracic Surgery, Associate Chief of Cardiac Surgery and Director of Minimally Invasive Cardiac Surgery at Mount Sinai Medical Center in New York; and Associate Professor of Surgery, Chief of Cardiovascular Surgery and Chair of The Cardiovascular Center at St. Joseph’s Hospital and Medical Center’s Heart and Lung Institute in Phoenix, Arizona.

Dr. Aklog received his clinical training in general and cardiothoracic surgery at Harvard’s Brigham and Women’s Hospital and Boston Children’s Hospital, including two years as the Medtronic Research Fellow at Harvard Medical School’s Cardiac Surgery Research Laboratory. He received advanced training in heart valve surgery under renowned cardiac surgeons Sir Magdi Yacoub at Harefield Hospital in London and Professor Alain Carpentier at L’Hopital Broussais in Paris as the American Association of Thoracic Surgery Traveling Fellow. Dr.

Aklog is a co-author on 38 peer-reviewed articles and 10 book chapters and is an inventor on 13 issued patents and over 30 patent applications.  He has served on the Editorial Board of the Journal of Cardiothoracic Surgery.  He has been a member and served in the leadership of several professional societies including as a member of the Board of Directors of the International Society for Minimally Invasive Cardiothoracic Surgery, and as President of the 21st Century Cardiothoracic Surgery Society in 2011.

Dr. Aklog received his A.B., magna cum laude, in Physics from Harvard University, where he was elected to Phi Beta Kappa. Dr. Aklog received his M.D., cum laude, from Harvard Medical School. The Company believes Dr. Aklog is well-qualified to serve on the Board due to his extensive experience in founding and building successful medical device companies, his distinguished career as an academic cardiac surgeon, his recognition as a thought leader and innovator both as a surgeon and a medical device entrepreneur and his widespread relationships in the healthcare and medical device communities.